Ann: Invex Therapeutics Lists on ASX, page-98

Like for like no doubt but some good news about the trial would be also an interesting read, the Mcap being so low is what is driving us up here..we still haven't hit $100m yet, if you look at NXS its gone from $100m to $400m+ since IPO. I think a clean register also helps, only 50% free float and alot being held by directors and those who put the deal together means you have to pay up. Will be interesting to see that once we hit 100m Mcap if any junior funds or index funds begin to start building a position as well.

I think we both know another stock that was done by similar backers of Invex that could do with an announcement or 2 on progress!